Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Keywords

Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineVirologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)

Affiliated Institutions

Related Publications

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

Bindu Bennet , Jayanthi Wolf , Rodrigo Laureano +1 more

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an ur...

2020 Toxicologic Pathology 47 citations

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Chih‐Cheng Lai , Tzu-Ping Shih , Wen‐Chien Ko +2 more

2020 International Journal of Antimicrobia... 6277 citations

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Ning Tang , Dengju Li , Xiong Wang +1 more

2020 Journal of Thrombosis and Haemostasis 5787 citations

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu , Hua Guo , Peng Zhou +1 more

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute re...

2020 Nature Reviews Microbiology 5269 citations

The proximal origin of SARS-CoV-2

Kristian G. Andersen , Andrew Rambaut , W. Ian Lipkin +2 more

2020 Nature Medicine 5448 citations

Publication Info

Year: 2020
Type: article
Volume: 395
Issue: 10234
Pages: 1407-1409
Citations: 550
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

550

OpenAlex

Cite This

APA Style

                            
                                
                                    Marc Feldmann, 
                                
                                    Ravinder N. Maini, 
                                
                                    James N. Woody
                                
                                et al.
                            
                            (2020). 
                            Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. 
                            The Lancet
                            , 395
                            (10234)
                            , 1407-1409.
                            https://doi.org/10.1016/s0140-6736(20)30858-8
                        

Identifiers

DOI: 10.1016/s0140-6736(20)30858-8